News Commentary | March 28, 2019
The aptly named CRISPR‑Chip analyzes purified DNA samples in minutes. At the heart of the technology is catalytically inactivated CRISPR‑Cas9 complexed to a specific single‑guide RNA, with the complex bound to a graphene‑based field‑effect transistor. The graphene layer's electrical sensitivity ... Not part of subscription
News Commentary | January 09, 2020
We've highlighted how point‑of‑care diagnostics (POCD) for acute conditions like infectious diseases must improve on speed to result, ease of use, reliability, and cost to be relevant. This is one such use case. The portable device uses small capillaries that trap E. coli bacteria (present in most ... Not part of subscription
News Commentary | March 18, 2020
The evolving COVID‑19 pandemic is in dire need of rapid actionable tests to mitigate the widespread infection it is causing. While efforts are in full swing across the globe to develop vaccines and scale up production of conventional diagnostic kits, a pressing need right now is to quickly identify ... To read more, click here.
by Nardev Ramanathan
As the coronavirus epidemic becomes a larger global threat, time is of the essence in diagnosing and treating patients. In our recent report, we highlighted how point-of-care diagnostics (POCD) for infectious diseases today still suffer from lack of speed and reliability. Cheek swabs, the primary diagnostic method, employ a PCR-based technique that takes a few hours at best. Alibaba and Ping An have developed an AI-based diagnostic that they claim can detect coronavirus-positive cases with 96% and 90% accuracy within 20 seconds and 15 seconds, respectively, from CT scans. Clients should monitor how these two giants deploy their solutions, especially if thy have interest in partnering to bring these solutions to other markets outside China.
For the original news article, click here .